Cargando…
Novel 1, 3-N, O-Spiroheterocyclic compounds inhibit heparanase activity and enhance nedaplatin-induced cytotoxicity in cervical cancer cells
Heparanase (HPA) is an enzyme that plays an important role in cancer metastasis and angiogenesis and is a potential target for molecular treatment of tumors. We previously found that abnormally high HPA expression in cervical cancer tissues is associated with poor survival and increased lymph node m...
Autores principales: | Song, Yanan, Hu, Bin, Qu, Hongjie, Wang, Lu, Zhang, Yunxiao, Tao, Jinchao, Cui, Jinquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094990/ https://www.ncbi.nlm.nih.gov/pubmed/27166252 http://dx.doi.org/10.18632/oncotarget.8959 |
Ejemplares similares
-
Recent Advances in the Synthesis of Spiroheterocycles via N-Heterocyclic Carbene Organocatalysis
por: Liu, Yue, et al.
Publicado: (2017) -
Suramin inhibits cell proliferation in ovarian and cervical cancer by downregulating heparanase expression
por: Li, HuaPing, et al.
Publicado: (2015) -
Nedaplatin: A Radiosensitizing Agent for Patients with Cervical Cancer
por: Mabuchi, Seiji, et al.
Publicado: (2011) -
Elucidation of the Relationship between CD Cotton Effects and the Absolute Configuration of Sixteen Stereoisomers of Spiroheterocyclic-Lactams
por: Yamada, Takeshi, et al.
Publicado: (2018) -
Spiroheterocyclic
Photocatalyst for Reducing QHIn-Persistent
Pollutants, Dyes, and Transition-Metal Ions Cocatalyzed with Electrolytes
por: Kumari, Renu, et al.
Publicado: (2022)